Article PDF
References
Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR : Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med 2006; 6: 501–514.
Tagami M, Yamagata K, Ikeda K, et al: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23–29.
Yoshii T, Iwai M, Li Z, et al: Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 2006; 29: 457–466.
Cheng ZJ, Vapaatalo H, Mervaala E : Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11: RA194–RA205.
Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM : Aldosterone mediates angiotensin II–induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB J 2006; 20: 1546–1548.
Zhao W, Swanson SA, Ye J, et al: Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II–dependent hypertension. Hypertension 2006; 48: 637–643.
Iwai M, Chen R, Li Z, et al: Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E–null mice. Circulation 2005; 112: 1636–1643.
Inomata H, Watanabe T, Iizuka Y, et al: Identification of quantitative trait loci for cardiac hypertrophy in two different strains of the spontaneously hypertensive rat. Hypertens Res 2005; 28: 273–281.
Tagami M, Yamagata K, Ikeda K, et al: Genetic vulnerability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23–29.
Goto M, Mukoyama M, Sugawara A, et al: Expression and role of angiotensin II type 2 receptor in the kidney and mesangial cells of spontaneously hypertensive rats. Hypertens Res 2002; 25: 125–133.
Nakaya H, Sasamura H, Kitamura Y, et al: Effects of angiotensin inhibitors on renal injury and angiotensin receptor expression in early hypertensive nephrosclerosis. Hypertens Res 1999; 22: 303–312.
Mollnau H, Wendt M, Szocs K, et al: Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: E58–E65.
Zalba G, Beaumont FJ, San Jose G, et al: Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000; 35: 1055–1061.
Akasaki T, Ohya Y, Kuroda J, et al: Increased expression of gp91phox homologues of NAD(P)H oxidase in the aortic media during chronic hypertension: involvement of the renin-angiotensin system. Hypertens Res 2006; 29: 813–820
Shiuchi T, Iwai M, Li HS, et al: Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension 2004; 43: 1003–1010.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwai, M., Mogi, M. & Horiuchi, M. Role of NAD(P)H Oxidase and Its Regulation in Chronic Hypertension. Hypertens Res 29, 743–744 (2006). https://doi.org/10.1291/hypres.29.743
Received:
Issue Date:
DOI: https://doi.org/10.1291/hypres.29.743